![Ross Raymond](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ross Raymond
Keine laufenden Positionen mehr
Profil
Ross Raymond was a Principal of eSub Solutions, Inc. Prior to eSub Solutions, he spent 5 years at Liquent, where he helped numerous pharmaceutical industry clients prototype, validate and implement electronic submission publishing technology.
Before joining Liquent, Mr. Raymond spent 15 years in clinical research and regulatory affairs at Burroughs Wellcome.
Prior to joining Burroughs Wellcome, he spent four years practicing as a Physician's Associate in oncology.
Mr. Raymond has 25 years of experience in clinical medicine, pharmaceutical clinical research/drug development and regulatory affairs strategies, operations and systems applications.
He received a BS degree in Biology at Ripon College and a postgraduate degree in Clinical Medicine from Yale University's Physician Associate program.
Ehemalige bekannte Positionen von Ross Raymond
Unternehmen | Position | Ende |
---|---|---|
AtheroGenics, Inc.
![]() AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | General Counsel | 14.07.2009 |
Ausbildung von Ross Raymond
Yale University | Graduate Degree |
Ripon College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
AtheroGenics, Inc.
![]() AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |